Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 12 citing articles:

Updated mechanisms of MASLD pathogenesis
Yuxuan Li, Peipei Yang, Jialu Ye, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 39
Biomarkers for Health Functional Foods in Metabolic Dysfunction-Associated Steatotic Liver Disorder (MASLD) Prevention: An Integrative Analysis of Network Pharmacology, Gut Microbiota, and Multi-Omics
Heng Yuan, Eun-Soo Jung, Soo-Wan Chae, et al.
Nutrients (2024) Vol. 16, Iss. 18, pp. 3061-3061
Open Access | Times Cited: 8
Research Progress on the Mechanism of Intestinal <i>Prevotella</i> Affecting the Occurrence and Development of Asthma
荟 刘
Advances in Clinical Medicine (2025) Vol. 15, Iss. 03, pp. 1050-1057
Closed Access
Gut microbiota differences, metabolite changes, and disease intervention during metabolic - dysfunction - related fatty liver progression
Jianzhong Shu, Yu-Han Huang, Xiaohong He, et al.
World Journal of Hepatology (2025) Vol. 17, Iss. 3
Closed Access
Non-Alcoholic Fatty Liver Disease, Awareness of a Diagnostic Challenge—A Clinician’s Perspective
Cristina Maria Mărginean, Denisa Pîrșcoveanu, Sergiu Marian Cazacu, et al.
Gastroenterology Insights (2024) Vol. 15, Iss. 4, pp. 1028-1053
Open Access | Times Cited: 1
The Association Between Prevotella copri and Advanced Fibrosis in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease
Madelaine Leitman, David Zhang, Shrey Pawar, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
The microbiome’s influence on obesity: mechanisms and therapeutic potential
Dawit Adisu Tadese, James Mwangi, Lei Luo, et al.
Science China Life Sciences (2024)
Closed Access
Fermented rhubarb alleviates metabolic dysfunction-associated steatotic liver disease symptoms by modulating gut microbiota and activating the hepatic insulin signaling pathway
Heng Yuan, Junyu Zhou, Ting Zhang, et al.
Food Bioscience (2024), pp. 105720-105720
Closed Access
Dietary Quality, Perceived Health, and Psychological Status as Key Risk Factors for Newly-Developed Metabolic Dysfunction-Associated Steatotic Liver Disease in a Longitudinal Study
Xuangao Wu, Ting Zhang, Sunmin Park
Nutrition (2024) Vol. 130, pp. 112604-112604
Closed Access
An Integrated Analysis of the Role of Gut Microbiome-Associated Metabolites in the Detection of MASH-Related Cirrhosis
Feixiang Xiong, Xuejie Zhang, Yuyong Jiang, et al.
Metabolites (2024) Vol. 14, Iss. 12, pp. 681-681
Open Access
Akkermansia muciniphila in patients with metabolic dysfunction-associated steatotic liver disease
Adina Ioana Mihele, Liviu Lazăr
Journal of Medicine and Life (2024) Vol. 17, Iss. 9, pp. 880-885
Open Access
Valorizing Agro‐Food Waste for Nutraceutical Development: Sustainable Approaches for Managing Metabolic Dysfunction‐Associated Steatotic Liver Disease and Related Co‐Morbidities
Laura Comi, Claudia Giglione, Fationa Tolaj, et al.
Food Frontiers (2024)
Open Access
Page 1

Scroll to top